Deep Learning to target Lung Cancer
In an article in the Lancet Digital Health, we demonstrate the value of performing both in silico and end-user validation modes and provide insight into instances where disagreements between them occur. Our results also underscore the importance of generating data on human factors given our incomplete understanding of this area, together with studying physicians' interactions with AI outputs and their overall satisfaction
AIM Investigators
